After participating in this activity, learners should be better able to: Describe current challenges in IBD care and the need for newer targeted therapeutic strategies Evaluate the role of IL-12 and IL-23 in IBD pathogenesis, including the relationship between IL-23 and CD64 Assess the most recent clinical and scientific data on current and emerging IL inhibitors for IBD Implement strategies to address current barriers to care and individualize IBD treatment for improved patient outcomes
- Provider:HMP Education
- Activity Link: https://hmpeducation.com/program/24-aibd-202
- Start Date: 2025-01-11 06:00:00
- End Date: 2025-01-11 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Janssen (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest